Has Gerald Deel received payments from drug or device companies?

Yes. Drug and device makers reported $2,893 in general payments to Gerald Deel across 144 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gerald Deel did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gerald Deel come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gerald Deel

Adult Health · Columbus, NCNPI 1740763697

Payments from drug & device makers

$2,893in general payments, 2019–2025

Across 144 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Alkermes, Inc.$408
Johnson & Johnson$399
Neurocrine Biosciences, Inc.$194
Otsuka America Pharmaceutical, Inc.$181
Sunovion Pharmaceuticals Inc.$131
plus $439 from 8 others

What the payments were for

Food & beverage$2,883100%
Education$100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	60	$1,140
Alkermes, Inc.	14	$408
Johnson & Johnson	12	$399
Neurocrine Biosciences, Inc.	11	$194
Otsuka America Pharmaceutical, Inc.	15	$181
Sunovion Pharmaceuticals Inc.	8	$131
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$85
Lundbeck LLC	5	$80
Vanda Pharmaceuticals Inc.	3	$75
Teva Pharmaceuticals USA, Inc.	5	$74
Indivior Inc.	3	$50
Takeda Pharmaceuticals U.S.A., Inc.	2	$32
Daiichi Sankyo Inc.	1	$25
Almatica Pharma LLC	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,893 in reported general payments places this provider in the 80th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	22	$33,867
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	68	$10,084
TrintellixVortioxetine Hydrobromide	11	$5,276
Ziprasidone Hcl	15	$1,244
Clozapine	37	$1,118
Duloxetine Hcl	40	$691
Aripiprazole	24	$681
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	26	$653
Fluvoxamine Maleate	12	$615
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	15	$600
Zolpidem Tartrate ErZolpidem Tartrate	11	$599
Alprazolam	93	$597
Doxepin Hcl	38	$493
Clonazepam	79	$441
Amitriptyline Hcl	11	$386

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$1,140	$33,86722 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix	$32	$5,27611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 614 adult health providers in North Carolina.

Other adult health in Columbus

Robert DodgeRaleigh$311K
Kimberly CampDurham$147K
Henry VanpalaRaleigh$110K
Jolene SpencerWashington$83K
Felicia RichardsonGreenville$64K
Anna BooneReidsville$51K
Chaely MedleyChapel Hill$47K
Ann ShumDurham$35K
Amy HopkinsGreenville$31K
Stephanie YatesDurham$19K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →